Frank Baldino
Guest
Frank Baldino
Guest
Hi all,
Well, Christina Hung from Goldman called it right at the March investor call when she asked if our management was going to change including #BullshitBob himself! Hahaha! I hope she shows up on the Aug 9 investor call.
The 'CEO of the Year' (who's never launched a successful commercial product in his life) has managed to tank the stock from a high in the upper $ teens to just about a buck today. Market cap is only just above $50 million. Investors are angry. We have class action lawsuits against Bob, Stan and Jeff for alleged SEC fraud. The Arymo ER launch is a disaster (what do Pat and Mark do exactly?). Sprix and Oxyado are yesterday's products. Our FDA relationship sucks so we can't get extra claims for Arymo nor Oxyado and the world is silent on 002.
So, when do you think #BullshitBob will get axed?
"The Guardian Technology platform is designed to make pills more resistant to physical and chemical manipulation, but Egalet's first approved product utilizing Guardian Technology, Arymo ER, did not receive all abuse-deterrent designations for which they were hoping. This could lead to a very slow stock price recovery for Egalet as much of their pipeline is reliant on Guardian Technology, which now seems like it will not be able to stand out in a crowded market."
Where do we go from here?
Well, Christina Hung from Goldman called it right at the March investor call when she asked if our management was going to change including #BullshitBob himself! Hahaha! I hope she shows up on the Aug 9 investor call.
The 'CEO of the Year' (who's never launched a successful commercial product in his life) has managed to tank the stock from a high in the upper $ teens to just about a buck today. Market cap is only just above $50 million. Investors are angry. We have class action lawsuits against Bob, Stan and Jeff for alleged SEC fraud. The Arymo ER launch is a disaster (what do Pat and Mark do exactly?). Sprix and Oxyado are yesterday's products. Our FDA relationship sucks so we can't get extra claims for Arymo nor Oxyado and the world is silent on 002.
So, when do you think #BullshitBob will get axed?
"The Guardian Technology platform is designed to make pills more resistant to physical and chemical manipulation, but Egalet's first approved product utilizing Guardian Technology, Arymo ER, did not receive all abuse-deterrent designations for which they were hoping. This could lead to a very slow stock price recovery for Egalet as much of their pipeline is reliant on Guardian Technology, which now seems like it will not be able to stand out in a crowded market."
Where do we go from here?